<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">cKx45cRwh97hGFkjPyxtmTq</article-id>
      <article-id pub-id-type="other">00014</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001500014</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500514</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000132</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Vari&#225;veis biopsicossociais e atitudes frente ao tratamento influenciam a hipertens&#227;o complicada</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pierin</surname>
            <given-names>Angela Maria Geraldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jesus</surname>
            <given-names>Elaine dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Augusto</surname>
            <given-names>M&#244;nica Aparecida de Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gusm&#227;o</surname>
            <given-names>Josiane</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ortega</surname>
            <given-names>K&#225;tia</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mion Jr</surname>
            <given-names>D&#233;cio</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Escola de Enfermagem </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>5</issue>
      <fpage>648</fpage>
      <lpage>654</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>05</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>06</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>21</day>
          <month>08</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A hipertens&#227;o complicada pode ser influenciada pelas caracter&#237;sticas dos pacientes hipertensos. OBJETIVO: Associar a condi&#231;&#227;o de hipertens&#227;o complicada com vari&#225;veis biossociais, tais como as atitudes e as cren&#231;as sobre a doen&#231;a e o tratamento e o bem-estar subjetivo. M&#201;TODOS: Foram estudados 251 hipertensos n&#227;o complicados (PAS &gt; 140 mmHg e/ou 90 &lt; PAD &lt; 110 mmHg para pacientes sem tratamento e PAD &lt; 110 mmHg para pacientes com tratamento, sem les&#245;es em &#243;rg&#227;os-alvo e outras doen&#231;as) e 260 hipertensos complicados (PAD &gt; 110 mmHg com ou sem tratamento, com les&#245;es em &#243;rg&#227;os-alvo ou outras doen&#231;as). RESULTADOS: Os hipertensos complicados foram significativamente diferentes dos n&#227;o complicados (p &lt; 0,05) em rela&#231;&#227;o a: 1 - Predom&#237;nio de homens, n&#227;o brancos (53,0%), maior &#237;ndice de massa corporal (29,5 &#177; 4,6 vs 28,5 &#177; 4,0 kg/m&#178;), mais de 10 anos de doen&#231;a (54,0%), realiza&#231;&#227;o de tratamento anterior (53,0%) e refer&#234;ncia de tristeza em rela&#231;&#227;o a sua vida como um todo (74,0%); 2 - Os hipertensos complicados nunca levam os rem&#233;dios quando viajam (59,0%), nem os providenciam antes de acabarem (71,0%) e raramente seguem as orienta&#231;&#245;es sobre alimenta&#231;&#227;o (69,0%); 3 - Os hipertensos n&#227;o complicados apontaram mais enxaqueca, dor articular e, entre as mulheres, presen&#231;a de menopausa e tratamento de reposi&#231;&#227;o hormonal; 4 - Dos que tinham a press&#227;o controlada (&lt; 140/90 mmHg), 61,9% eram hipertensos n&#227;o complicados; e 5 - Os hipertensos complicados desconheciam que o tratamento pode evitar problemas renais e desconheciam ainda que a hipertens&#227;o tamb&#233;m pode acometer pessoas jovens. CONCLUS&#195;O: Hipertensos complicados apresentaram mais caracter&#237;sticas estruturais e psicossociais desfavor&#225;veis, mais atitudes negativas frente ao tratamento e desconhecem a doen&#231;a.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Hipertens&#227;o</kwd>
        <kwd>Hipertens&#227;o</kwd>
        <kwd>recusa do paciente ao tratamento</kwd>
        <kwd>hipertens&#227;o</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>01</day>
        <month>10</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>Vari&#225;veis biopsicossociais e atitudes frente ao tratamento influenciam a hipertens&#227;o complicada</p>
    <p>
      <bold>Angela Maria Geraldo Pierin<sup>I</sup>; Elaine dos Santos Jesus<sup>I</sup>; M&#244;nica Aparecida de Oliveira Augusto<sup>I</sup>; Josiane Gusm&#227;o<sup>II</sup>; K&#225;tia Ortega<sup>II</sup>; D&#233;cio Mion Jr<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Escola de Enfermagem - Universidade de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil </p>
    <p><sup>II</sup>Unidade de Hipertens&#227;o - Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A hipertens&#227;o complicada pode ser influenciada pelas caracter&#237;sticas dos pacientes hipertensos. </p>
    <p><bold>OBJETIVO:</bold> Associar a condi&#231;&#227;o de hipertens&#227;o complicada com vari&#225;veis biossociais, tais como as atitudes e as cren&#231;as sobre a doen&#231;a e o tratamento e o bem-estar subjetivo. </p>
    <p><bold>M&#201;TODOS:</bold> Foram estudados 251 hipertensos n&#227;o complicados (PAS <underline>&gt;</underline> 140 mmHg e/ou 90 <underline>&lt;</underline> PAD &lt; 110 mmHg para pacientes sem tratamento e PAD &lt; 110 mmHg para pacientes com tratamento, sem les&#245;es em &#243;rg&#227;os-alvo e outras doen&#231;as) e 260 hipertensos complicados (PAD <underline>&gt;</underline> 110 mmHg com ou sem tratamento, com les&#245;es em &#243;rg&#227;os-alvo ou outras doen&#231;as). </p>
    <p><bold>RESULTADOS:</bold> Os hipertensos complicados foram significativamente diferentes dos n&#227;o complicados (p &lt; 0,05) em rela&#231;&#227;o a: 1 - Predom&#237;nio de homens, n&#227;o brancos (53,0%), maior &#237;ndice de massa corporal (29,5 &#177; 4,6 <italic>vs</italic> 28,5 &#177; 4,0 kg/m<sup>2</sup>), mais de 10 anos de doen&#231;a (54,0%), realiza&#231;&#227;o de tratamento anterior (53,0%) e refer&#234;ncia de tristeza em rela&#231;&#227;o a sua vida como um todo (74,0%); 2 - Os hipertensos complicados nunca levam os rem&#233;dios quando viajam (59,0%), nem os providenciam antes de acabarem (71,0%) e raramente seguem as orienta&#231;&#245;es sobre alimenta&#231;&#227;o (69,0%); 3 - Os hipertensos n&#227;o complicados apontaram mais enxaqueca, dor articular e, entre as mulheres, presen&#231;a de menopausa e tratamento de reposi&#231;&#227;o hormonal; 4 - Dos que tinham a press&#227;o controlada (&lt; 140/90 mmHg), 61,9% eram hipertensos n&#227;o complicados; e 5 - Os hipertensos complicados desconheciam que o tratamento pode evitar problemas renais e desconheciam ainda que a hipertens&#227;o tamb&#233;m pode acometer pessoas jovens. </p>
    <p><bold>CONCLUS&#195;O:</bold> Hipertensos complicados apresentaram mais caracter&#237;sticas estruturais e psicossociais desfavor&#225;veis, mais atitudes negativas frente ao tratamento e desconhecem a doen&#231;a.</p>
    <p><bold>Palavras-chave:</bold> Hipertens&#227;o/complica&#231;&#245;es/terapia, recusa do paciente ao tratamento, hipertens&#227;o/aspectos psicossociais.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Estudos epidemiol&#243;gicos demonstram que n&#237;veis elevados de press&#227;o arterial aumentam o risco de doen&#231;a vascular cerebral<sup>1</sup>, doen&#231;as arteriais coronarianas<sup>2</sup>, insufici&#234;ncia card&#237;aca congestiva<sup>3</sup>, insufici&#234;ncia renal cr&#244;nica<sup>4</sup> e acometimento vascular<sup>5</sup>. Al&#233;m disso, a hipertens&#227;o arterial apresenta preval&#234;ncia elevada e, em nosso meio, sua frequ&#234;ncia varia entre 22,3% e 43,9%<sup>6</sup>. Entretanto, os &#237;ndices de controle da doen&#231;a s&#227;o baixos, em torno de 30,0%<sup>7,8</sup>, dentre outros fatores, principalmente devido &#224; baixa ades&#227;o ao tratamento. Nesse sentido, &#233; importante identificar fatores que possam interferir no processo de ades&#227;o, sejam relacionados ao paciente, &#224; doen&#231;a, ao tratamento e aos aspectos institucionais, dentre outros. </p>
    <p>Dentre os aspectos relacionados ao hipertenso que podem influenciar a ades&#227;o ao tratamento, ressaltam-se o g&#234;nero, idade, etnia, estado civil, escolaridade e n&#237;vel socioecon&#244;mico. Tamb&#233;m as cren&#231;as de sa&#250;de e h&#225;bitos de vida merecem destaque. Em rela&#231;&#227;o &#224; doen&#231;a, s&#227;o relevantes o conhecimento, a cronicidade, a aus&#234;ncia de sintomas e as consequ&#234;ncias tardias. Custo, efeitos indesej&#225;veis das drogas, esquemas complexos e piora da qualidade de vida s&#227;o fatores relativos ao tratamento medicamentoso anti-hipertensivo<sup>9</sup>, nesse sentido, os m&#233;todos usados para reduzir a press&#227;o arterial n&#227;o devem interferir negativamente na qualidade de vida do paciente<sup>10</sup>.</p>
    <p>Outro ponto que se destaca &#233; que geralmente os hipertensos podem apresentar comorbidades ou les&#245;es em &#243;rg&#227;os-alvo ("hipertensos complicados"), que requerem outros tratamentos espec&#237;ficos e que podem aumentar a dificuldade do controle da hipertens&#227;o arterial. Dentre as comorbidades mais frequentes, est&#227;o o diabete melito, as insufici&#234;ncia card&#237;aca e renal, a doen&#231;a coronariana e o acidente vascular cerebral, que aumentam o risco de mortalidade cardiovascular.</p>
    <p>Nesse contexto, os profissionais da &#225;rea da sa&#250;de, que atuam junto aos hipertensos, t&#234;m papel fundamental no sentido de caracterizar a problem&#225;tica do hipertenso, levando em considera&#231;&#227;o todos os aspectos relacionados &#224;s suas caracter&#237;sticas, de modo que, embasados em dados reais e concretos, tenham condi&#231;&#245;es para planejar e prestar assist&#234;ncia individualizada a fim de favorecer a ades&#227;o ao tratamento, com o controle efetivo da doen&#231;a.</p>
    <p>Dessa forma, o presente estudo teve como objetivo associar a condi&#231;&#227;o de hipertens&#227;o complicada e n&#227;o complicada com as seguintes vari&#225;veis: 1) biossociais; 2) atitudes e cren&#231;as sobre a doen&#231;a e tratamento; 2) controle da press&#227;o arterial; e 4) sentimento em rela&#231;&#227;o &#224; vida como um todo. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>O estudo foi realizado no servi&#231;o ambulatorial da Liga de Hipertens&#227;o do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, ap&#243;s aprova&#231;&#227;o pelo Comit&#234; de &#201;tica. O estudo teve como crit&#233;rios de inclus&#227;o: hipertensos acima de 18 anos, de ambos os sexos, sem restri&#231;&#227;o de ra&#231;a, com concord&#226;ncia do paciente para a participa&#231;&#227;o no estudo e assinatura do Termo de Consentimento Livre e Esclarecido. Uma amostra de conveni&#234;ncia de 511 hipertensos foi composta, com recusa m&#237;nima para participa&#231;&#227;o no estudo.</p>
    <p>Os hipertensos foram classificados em complicados ou n&#227;o complicados. O grupo n&#227;o complicado incluiu 251 pacientes com press&#227;o sist&#243;lica <underline>&gt;</underline> 140 mmHg e/ou press&#227;o diast&#243;lica &lt; 110 mmHg e <underline>&gt;</underline> 90 mmHg para pacientes sem tratamento, e press&#227;o diast&#243;lica &lt; 110 mmHg para pacientes com tratamento medicamentoso, ou seja, hipertensos est&#225;gio um ou dois<sup>6</sup>, que n&#227;o apresentavam les&#245;es em &#243;rg&#227;os-alvo clinicamente evidentes ou doen&#231;as associadas (infarto agudo do mioc&#225;rdio, acidente vascular cerebral, diabete melito, insufici&#234;ncia card&#237;aca, insufici&#234;ncia renal e/ou nefropatias). O grupo complicado incluiu 260 hipertensos com press&#227;o diast&#243;lica <underline>&gt;</underline> 110 mmHg com ou sem tratamento, ou seja hipertensos est&#225;gio tr&#234;s<sup>6</sup>, ou hipertensos com press&#227;o diast&#243;lica <underline>&lt;</underline> 110 ou &gt; 110 mmHg, que apresentassem les&#245;es em &#243;rg&#227;os-alvo clinicamente evidentes ou outras doen&#231;as associadas, conforme descritas anteriormente. </p>
    <p>Os dados foram coletados atrav&#233;s de entrevista com os pacientes, utilizando-se um formul&#225;rio pr&#243;prio, com dados de identifica&#231;&#227;o, aspecto econ&#244;mico e social, fatores que podem interferir na ades&#227;o ao tratamento, cren&#231;as e conhecimento sobre a doen&#231;a e sobre o tratamento. Os valores da press&#227;o arterial considerados foram os resultados da m&#233;dia da 4&#170; e da 5&#170; medidas, de uma sequ&#234;ncia de 5 realizadas com aparelho autom&#225;tico validado (DIXTAL DX2710)<sup>11</sup>, tipo oscilom&#233;trico, com o paciente sentado, bra&#231;o apoiado na altura do cora&#231;&#227;o, com uso de manguito de tamanho adequado, em ambiente calmo, sem estar com a bexiga cheia, sem ter fumado, ingerido bebida cafe&#237;nada ou refei&#231;&#245;es h&#225; pelo menos 30 minutos, al&#233;m de n&#227;o ter realizado atividade f&#237;sica h&#225; 60 a 90 minutos. Para avaliar o sentimento do hipertenso em rela&#231;&#227;o &#224; sua vida, foi usado um diagrama com 7 figuras de faces, Escala de Faces de Andrews, que &#233; uma escala visual intervalar de 7 pontos, composta por faces estilizadas, referindo-se ao estado de humor que predominou frente &#224; quest&#227;o "Qual dessas faces melhor representa sua vida como um todo?"<sup>12</sup>.</p>
    <p>As vari&#225;veis classificat&#243;rias s&#227;o apresentadas descritivamente em tabelas contendo frequ&#234;ncias absolutas (n) e relativas (%). A rela&#231;&#227;o entre as vari&#225;veis foram avaliadas com o teste qui-quadrado, teste da raz&#227;o de verossimilhan&#231;a ou teste exato de Fisher. </p>
    <p>As vari&#225;veis quantitativas s&#227;o apresentadas em tabelas contendo m&#233;dia e desvio-padr&#227;o. Nas vari&#225;veis quantitativas, est&#227;o inclu&#237;dos idade, circunfer&#234;ncia abdominal, &#237;ndice de massa corporal e valores da press&#227;o arterial. As m&#233;dias, segundo os fatores, foram comparadas com testes param&#233;tricos (teste <italic>t</italic> de <italic>Student</italic> ou an&#225;lise de vari&#226;ncia) ou com testes n&#227;o param&#233;tricos (teste da soma de postos de Wilcoson ou Kruskal-Wallis). O n&#237;vel de signific&#226;ncia adotado foi 0,05. Os dados foram processados no sistema <italic>SPSS</italic> 7.5.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>
      <bold>Caracter&#237;sticas dos hipertensos</bold>
    </p>
    <p>Foram estudados 511 hipertensos, com predom&#237;nio do sexo feminino (67,9), da cor branca (56,4%), casados (66,9%), escolaridade de 1&#186; Grau (57,9%), pessoas que exerciam atividades do lar (43,2%) e renda familiar de at&#233; 5 sal&#225;rios m&#237;nimos (56,0%). A m&#233;dia de idade manteve-se na 5&#170; d&#233;cada (53 &#177; 11 anos), o &#237;ndice de massa corporal permaneceu no limite superior da faixa de sobrepeso (29,04 &#177; 4,35 kg/m<sup>2</sup>). Em rela&#231;&#227;o &#224; medida da cintura, 32,9% dos homens tinham circunfer&#234;ncia abdominal maior que 102 cm e 74,1% das mulheres acima de 88 cm, que s&#227;o os limites m&#225;ximos tolerados. A m&#233;dia de press&#227;o arterial foi de 151/92 mmHg. Quanto aos h&#225;bitos de vida, 13,4% eram tabagistas e um ter&#231;o ex-tabagistas; 9,0% eram etilistas e 15,0% ex-etilistas. Apenas 22,6% referiram praticar atividade f&#237;sica regularmente. Em rela&#231;&#227;o ao diagn&#243;stico da doen&#231;a, a maioria (65,8%) sabia ser hipertenso h&#225; mais de 5 anos e cerca da metade (51,5%) n&#227;o tinha o h&#225;bito de medir a press&#227;o, e os que mediam o faziam em servi&#231;os de sa&#250;de, em casa ou na farm&#225;cia.</p>
    <p>
      <bold>Vari&#225;veis que se associaram com os hipertensos complicados e n&#227;o complicados</bold>
    </p>
    <p>Nas caracter&#237;sticas biossociais e antropom&#233;tricas, os hipertensos complicados eram (p &lt; 0,05) mais do sexo masculino, n&#227;o brancos, respons&#225;veis pela renda familiar, com n&#237;veis mais elevados de press&#227;o arterial, do &#237;ndice de massa corporal e da circunfer&#234;ncia abdominal (<xref ref-type="table" rid="tab01">Tabela 1</xref>).</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt01.jpg"/></table-wrap>
    <p>Em rela&#231;&#227;o &#224;s atitudes frente ao tratamento da hipertens&#227;o, os hipertensos complicados informaram mais atitudes negativas (p &lt; 0,05), pois nunca ou raramente levam os rem&#233;dios quando viajam, n&#227;o adquirem os medicamentos antes que acabem e tamb&#233;m nunca ou raramente seguem as orienta&#231;&#245;es sobre a alimenta&#231;&#227;o (<xref ref-type="table" rid="tab02">Tabela 2</xref>).</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt02.jpg"/></table-wrap>
    <p>Verificou-se tamb&#233;m que os hipertensos complicados foram significativamente distintos (p &lt; 0,05) dos n&#227;o complicados por apresentarem mais refer&#234;ncia de dificuldade de ere&#231;&#227;o e emagrecimento. Em contrapartida, os hipertensos n&#227;o complicados referiram mais sintomas como enxaqueca e dor nas articula&#231;&#245;es. Dentre as mulheres, as hipertensas n&#227;o complicadas estavam mais na menopausa e faziam tratamento de reposi&#231;&#227;o hormonal (p &lt; 0,05). Como esperado, os n&#237;veis de press&#227;o arterial foram mais elevados nos hipertensos complicados e, dentre o total dos hipertensos que apresentaram a press&#227;o controlada (&lt; 140/90 mmHg), a maioria (61,9%) era de hipertensos n&#227;o complicados (<xref ref-type="table" rid="tab03">Tabela 3</xref>). </p>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt03.jpg"/></table-wrap>
    <p>Destaca-se ainda que a condi&#231;&#227;o de ser hipertenso complicado se associou com as seguintes vari&#225;veis (p &lt; 0,05): procurou o servi&#231;o por conta pr&#243;pria, tem mais tempo de hipertens&#227;o, j&#225; fez tratamento anterior, faz uso de tratamento medicamentoso anti-hipertensivo e j&#225; usou outros tratamentos, como rem&#233;dios caseiros e ch&#225;s. Por outro lado, os n&#227;o complicados mediram a press&#227;o e estava normal h&#225; menos tempo. Em rela&#231;&#227;o ao conhecimento sobre a doen&#231;a, o grupo complicado apresentou pouco conhecimento, achando que o tratamento n&#227;o pode evitar problemas renais e que pessoas jovens n&#227;o t&#234;m press&#227;o alta (<xref ref-type="table" rid="tab04">Tabela 4</xref>).</p>
    <table-wrap id="tab04">
      <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt04.jpg"/></table-wrap>
    <p>De acordo com os dados da <xref ref-type="table" rid="tab05">Tabela 5</xref>, ao serem questionados como se sentiam em rela&#231;&#227;o &#224; sua vida como um todo, os hipertensos n&#227;o complicados apontaram mais a face 1, que se relaciona a um maior grau de contentamento, e os complicados, a face 7, que caracteriza um menor grau de satisfa&#231;&#227;o em rela&#231;&#227;o &#224; sua vida como um todo (p &lt; 0,05). </p>
    <table-wrap id="tab05">
      <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt05.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O presente estudo mostrou que houve distin&#231;&#227;o entre os grupos de hipertensos complicados e n&#227;o complicados quanto &#224;s caracter&#237;sticas socioestruturais, controle da hipertens&#227;o, atitudes e conhecimento sobre a doen&#231;a e tratamento, predominando no grupo complicado, vari&#225;veis que podem interferir na obten&#231;&#227;o de &#234;xito na realiza&#231;&#227;o do tratamento.</p>
    <p>Os principais resultados mostraram que os hipertensos complicados eram mais do sexo masculino, n&#227;o brancos e respons&#225;veis pela renda familiar. A vari&#225;vel g&#234;nero merece aten&#231;&#227;o, pois pode estar respaldada no fato de que as mulheres, por sua condi&#231;&#227;o espec&#237;fica, demonstram maior conscientiza&#231;&#227;o com sua sa&#250;de, o que pode resultar em maior ades&#227;o ao tratamento. Estudos t&#234;m revelado a rela&#231;&#227;o entre hipertens&#227;o e g&#234;nero<sup>13-15</sup>. </p>
    <p>Investiga&#231;&#227;o sobre a preval&#234;ncia da hipertens&#227;o arterial referida, sobre a percep&#231;&#227;o de sua origem e formas de controle em &#225;rea metropolitana de S&#227;o Paulo, mostrou que as mulheres foram as que mais procuraram por assist&#234;ncia. Pondera-se que as mulheres parecem ter uma percep&#231;&#227;o mais acurada de sua condi&#231;&#227;o de sa&#250;de e tamb&#233;m desenvolvem maiores rela&#231;&#245;es com os servi&#231;os de sa&#250;de em raz&#227;o de seus atributos e fun&#231;&#245;es reprodutivas<sup>16</sup>. Outro estudo, realizado em um ambulat&#243;rio de um hospital-escola da cidade de S&#227;o Paulo, evidenciou que a falta de conhecimento sobre a doen&#231;a e o tratamento tamb&#233;m se associou com o sexo masculino e n&#237;veis de press&#227;o arterial mais elevados<sup>17</sup>. </p>
    <p>Da mesma forma que o g&#234;nero, a etnia tamb&#233;m tem se associado com a hipertens&#227;o. No presente estudo, a maioria dos hipertensos complicados era formada por n&#227;o brancos (negra, mulata, mesti&#231;a), o que confirma a preval&#234;ncia de maiores complica&#231;&#245;es nessas etnias, como revelado no estudo em que a preval&#234;ncia de acidente vascular cerebral foi significantemente maior em hipertensos negros ou mulatos do que em brancos, atendidos em um servi&#231;o de refer&#234;ncia para hipertens&#227;o arterial da cidade de Salvador, BA<sup>18</sup>. Tamb&#233;m nessa mesma cidade, relacionou-se ra&#231;a e ades&#227;o ao tratamento em um ambulat&#243;rio de hipertens&#227;o. Os dados mostraram que os pacientes de cor branca aderiram mais &#224;s consultas e ao tratamento do que os pacientes de ra&#231;a negra. Os negros compareceram menos ao tratamento e apresentaram n&#237;veis press&#243;ricos mais elevados<sup>19</sup>. </p>
    <p>Deve-se destacar que a associa&#231;&#227;o entre etnia e hipertens&#227;o est&#225; intimamente relacionada &#224;s condi&#231;&#245;es socioecon&#244;micas pouco favor&#225;veis a que essas pessoas est&#227;o sujeitas, o que pode ser exemplificado pelo fato de que, no grupo dos hipertensos complicados, os respons&#225;veis pela renda familiar eram os pr&#243;prios pacientes. Tal situa&#231;&#227;o pode demandar mais preocupa&#231;&#245;es, o que talvez possa ser decorrente da maior responsabilidade na sua vida di&#225;ria, &#224;s vezes deixando de lado os cuidados com a pr&#243;pria sa&#250;de. </p>
    <p>V&#225;rios fatores de estilo de vida parecem influenciar diretamente os n&#237;veis da press&#227;o arterial, sendo a obesidade um dos mais importantes, o que pode ser referendado pelo achado de que a m&#233;dia do &#237;ndice de massa corporal dos hipertensos estudados esteve no limite superior da faixa de sobrepeso. Quando analisados os dois grupos estudados, os hipertensos complicados apresentaram n&#237;veis mais elevados de press&#227;o arterial, do &#237;ndice de massa corporal e da m&#233;dia da circunfer&#234;ncia abdominal. </p>
    <p>A pandemia da obesidade atual &#233; de grande import&#226;ncia, pois afeta profundamente a qualidade de vida das pessoas, tornando-se um grande problema na sociedade, por ser um importante fator de risco cardiovascular. A literatura sobre esse assunto &#233; ampla e contundente. </p>
    <p>Investiga&#231;&#227;o de Carneiro e cols.<sup>20</sup> mostrou maior preval&#234;ncia de hipertens&#227;o entre os indiv&#237;duos com obesidade grau III (67,1% hipertensos com IMC <underline>&gt;</underline> 40 kg/m<sup>2</sup>) em rela&#231;&#227;o &#224;queles com sobrepeso (23,0% hipertensos com IMC <underline>&gt;</underline> 25 e <underline>&lt;</underline> 29,9 kg/m<sup>2</sup>). Ap&#243;s estratifica&#231;&#227;o por idade, o maior aumento do risco de hipertens&#227;o ocorreu entre os jovens, grupo no qual este risco alcan&#231;ou valor 7,5 vezes maior que nos indiv&#237;duos com &#237;ndice de massa corporal entre 25 e 29,9 kg/m<sup>2 20</sup>. </p>
    <p>Em rela&#231;&#227;o &#224; obesidade abdominal, dados que foram avaliados em um estudo, que analisou a circunfer&#234;ncia da cintura e o &#237;ndice de massa corporal como prognosticadores da hipertens&#227;o arterial, indicaram aumento significativo da preval&#234;ncia da hipertens&#227;o com o aumento da circunfer&#234;ncia da cintura, para o total de homens. Para as mulheres, independentemente da faixa et&#225;ria, a preval&#234;ncia da hipertens&#227;o aumentou tanto com o aumento do &#237;ndice de massa corporal, quanto com o aumento da circunfer&#234;ncia da cintura<sup>21</sup>.</p>
    <p>Em outro estudo, observou-se que idade, triglicer&#237;deos, circunfer&#234;ncia da cintura e sexo foram fatores de risco independentes associados &#224; hipertens&#227;o<sup>22</sup>. Al&#233;m de que a obesidade abdominal &#233; um dos componentes da s&#237;ndrome metab&#243;lica e tem sido relacionada com maior risco cardiovascular<sup>23</sup>.</p>
    <p>Acrescentam-se ao cen&#225;rio de fatores intervenientes na consecu&#231;&#227;o adequada do tratamento anti-hipertensivo, as atitudes frente ao mesmo. Os hipertensos complicados, quando comparados aos n&#227;o complicados, apresentam mais comportamentos que podem influenciar negativamente, como nunca ou raramente levar os rem&#233;dios quando viajam, n&#227;o seguir as orienta&#231;&#245;es sobre alimenta&#231;&#227;o e n&#227;o providenciar os rem&#233;dios antes que acabem. Dessa forma, a ades&#227;o ao tratamento fica prejudicada, com consequente controle menos satisfat&#243;rio da hipertens&#227;o arterial. Os comportamentos e as atitudes est&#227;o arraigados na conduta das pessoas e requerem da equipe de sa&#250;de conhecimento e habilidade de pr&#225;ticas de educa&#231;&#227;o a fim de se obter mudan&#231;as ou minimizar atitudes que possam comprometer a realiza&#231;&#227;o adequada do tratamento. </p>
    <p>A educa&#231;&#227;o das pessoas com doen&#231;as cr&#244;nicas, como a hipertens&#227;o, tem como finalidade influenciar o comportamento do paciente na obten&#231;&#227;o de mudan&#231;as e manuten&#231;&#227;o das mesmas. Os objetivos se relacionam a: ajudar o paciente a entender, conhecer e aceitar a doen&#231;a; conhecer e reconhecer comportamentos de risco; informar sobre decis&#245;es do tratamento e diagn&#243;stico; negociar e cumprir propostas de tratamento; e enfrentar problemas de manuten&#231;&#227;o do tratamento<sup>16</sup>. Assim, o tratamento do paciente portador de doen&#231;a cr&#244;nica deve favorecer a adapta&#231;&#227;o a tal condi&#231;&#227;o, instrumentalizando-o para que, por meio de seus pr&#243;prios recursos, desenvolva mecanismos que permitam conhecer seu processo sa&#250;de/doen&#231;a de modo a identificar, evitar e prevenir complica&#231;&#245;es, agravos e, sobretudo, mortalidade precoce<sup>24</sup>.</p>
    <p>A presen&#231;a de comorbidades associadas &#224; hipertens&#227;o complicada, como por exemplo o diabete, j&#225; era um fato esperado, tendo em vista que fazia parte dos crit&#233;rios de inclus&#227;o para este grupo. Por&#233;m, a hipertens&#227;o arterial e o diabete melito representam importantes problemas de sa&#250;de p&#250;blica em nosso meio, em fun&#231;&#227;o das altas taxas de preval&#234;ncias, suas complica&#231;&#245;es, al&#233;m de se configurarem como importantes fatores de risco associados &#224;s doen&#231;as cardiovasculares, que por sua vez ocupam o primeiro lugar no perfil de morbimortalidade. </p>
    <p>A sobrevida dos pacientes, as barreiras para o acesso aos servi&#231;os de sa&#250;de, aspectos do comportamento que determinam a procura espont&#226;nea de cuidados preventivos ou curativos s&#227;o fatores que podem influenciar na preval&#234;ncia de complica&#231;&#245;es de &#243;rg&#227;os-alvo da hipertens&#227;o arterial em pacientes avaliados ambulatorialmente<sup>18</sup>. </p>
    <p>Ressaltam-se ainda os custos sociais e econ&#244;micos, decorrentes da assist&#234;ncia &#224; sa&#250;de, a aposentadoria precoce, o absente&#237;smo ao trabalho e outras incapacidades. </p>
    <p>Em rela&#231;&#227;o &#224; presen&#231;a de outros problemas de sa&#250;de, os hipertensos n&#227;o complicados apresentaram mais sintomas, como por exemplo enxaqueca, o que pode ser explicado pela maior concentra&#231;&#227;o de mulheres neste grupo e tal altera&#231;&#227;o est&#225; mais presente no sexo feminino<sup>25</sup>. Ainda em rela&#231;&#227;o &#224;s mulheres n&#227;o complicadas, verificou-se que realizavam mais tratamento de reposi&#231;&#227;o hormonal, quando comparadas com as hipertensas complicadas. A rela&#231;&#227;o entre o tratamento de reposi&#231;&#227;o hormonal ap&#243;s a menopausa e a prote&#231;&#227;o para as doen&#231;as cardiovasculares ainda &#233; bastante discutida, por&#233;m, estudo de Scuteri e colegas verificou que, em hipertensas sob essa terapia, houve pequena redu&#231;&#227;o da press&#227;o sist&#243;lica<sup>26</sup>. Al&#233;m disso, as mulheres tendem a procurar mais pela assist&#234;ncia e parecem ter uma percep&#231;&#227;o mais acurada de sua condi&#231;&#227;o de sa&#250;de, desenvolvendo maiores rela&#231;&#245;es com os servi&#231;os de sa&#250;de em raz&#227;o de seus atributos e fun&#231;&#245;es reprodutivas. </p>
    <p>Destaca-se ainda que a refer&#234;ncia de "dificuldade de ere&#231;&#227;o" foi mais apontada pelos hipertensos complicados, o que pode ser justificada principalmente pela associa&#231;&#227;o da hipertens&#227;o arterial e diabete, pelo uso de n&#250;mero maior de medicamentos, pelas outras comorbidades como insufici&#234;ncia renal ou at&#233; porque neste grupo a maioria era do sexo masculino. </p>
    <p>Outros achados que podem influenciar a condi&#231;&#227;o dos hipertensos complicados foram maior tempo de doen&#231;a e de tratamento associados a pouco conhecimento, como n&#227;o saber que o tratamento pode evitar problemas renais e que pessoas jovens podem ter hipertens&#227;o arterial. O conhecimento sobre a doen&#231;a e sobre o tratamento tamb&#233;m &#233; uma vari&#225;vel a ser considerada no contexto da ades&#227;o ao tratamento. </p>
    <p>De um modo geral, dados de estudos<sup>7,27,28</sup> mostram que os hipertensos possuem a informa&#231;&#227;o sobre sua problem&#225;tica de sa&#250;de, por&#233;m n&#227;o est&#227;o devidamente controlados. A discrep&#226;ncia entre ter informa&#231;&#227;o a respeito da doen&#231;a e tratamento e conseguir controlar a press&#227;o arterial aponta para a diferen&#231;a essencial entre conhecimento e ades&#227;o. </p>
    <p>Acrescenta-se ainda que, na tentativa de se avaliar como se sentiam em rela&#231;&#227;o &#224; sua vida como um todo, que seria uma possibilidade de avalia&#231;&#227;o de qualidade de vida, a presente investiga&#231;&#227;o verificou que os hipertensos complicados apontaram mais insatisfa&#231;&#227;o do que os hipertensos n&#227;o complicados. A rela&#231;&#227;o entre caracter&#237;sticas da personalidade e ades&#227;o ao tratamento &#233; controversa, por&#233;m, vari&#225;veis, como sentimento de bem-estar, socializa&#231;&#227;o e capacidade de ser igual a outros, s&#227;o elementos de medida da personalidade e podem se associar com a ades&#227;o ao tratamento, contribuindo para o controle da doen&#231;a<sup>29,30</sup>. </p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Entre os hipertensos complicados, caracter&#237;sticas estruturais e psicossociais desfavor&#225;veis, atitudes negativas frente ao tratamento e desconhecimento sobre a doen&#231;a podem ter tido influ&#234;ncia no baixo percentual de controle da press&#227;o arterial verificado. </p>
    <p>N&#227;o se descarta a possibilidade de limita&#231;&#245;es do estudo, comum em estudos observacionais, tais como possibilidades de vi&#233;s de sele&#231;&#227;o, envolvimento de fatores de confus&#227;o e achados ocasionais na an&#225;lise. Por&#233;m, considera-se que os profissionais da &#225;rea da sa&#250;de que atuam junto aos hipertensos devem prover estrat&#233;gias diferenciadas e planejar suas a&#231;&#245;es para prestar uma assist&#234;ncia ampla e de qualidade que atenda &#224;s reais necessidades destes pacientes.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Angela Maria Geraldo Pierin </p>
        <p> Rua Heitor Penteado, 250 ap. 63 - Sumar&#233; </p>
        <p> 05438-000 - S&#227;o Paulo, SP - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="pierin@usp.br">pierin@usp.br</email>
        </p>
      </fn>
    </p>
    <p> Artigo recebido em 20/05/09; revisado recebido em 21/08/09; aceito em 09/06/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364 (9438): 937-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study</article-title>
          <source>Lancet</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>937</fpage>
          <lpage>52</lpage>
          <issue>9438</issue>
          <volume>364</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yusuf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hawken</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ounpuu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dans</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Avezum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lanas</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Hennekens CH, Albert CM, Godfriend SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarction  evidence from clinical trials. N Engl J Med. 1996; 335 (22): 1660-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Adjunctive drug therapy of acute myocardial infarction - evidence from clinical trials</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1660</fpage>
          <lpage>7</lpage>
          <issue>22</issue>
          <volume>335</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hennekens</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Godfriend</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Gaziano</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Buring</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, et al. AHA Consensus Panel Statement: prevention heart attack and death in patients with coronary disease: the Secondary Prevention Panel. J Am Coll Cardiol. 1995; 26 (1): 292-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>AHA Consensus Panel Statement: prevention heart attack and death in patients with coronary disease: the Secondary Prevention Panel</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>292</fpage>
          <lpage>4</lpage>
          <issue>1</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Smith Jr</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Blair</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Fuster</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gersh</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139 (11): 901-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study</article-title>
          <source>Ann Intern Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>901</fpage>
          <lpage>6</lpage>
          <issue>11</issue>
          <volume>139</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wachtell</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ibsen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Borch-Johnsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lindholm</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Mogensen</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002; 143 (6): 961-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>961</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>143</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Murabito</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Nieto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Mion Jr D, Kohlmann Jr O, Machado CA, Amodeo C, Gomes MAM, Praxedes JN, et al. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de Hipertens&#227;o / Sociedade Brasileira de Nefrologia. V Diretrizes brasileiras de hipertens&#227;o arterial. Arq Bras Cardiol. 2007; 89 (3): e24-79.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>V Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>e24</fpage>
          <lpage>79</lpage>
          <issue>3</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mion Jr</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kohlmann Jr</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Amodeo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>MAM</given-names>
            </name>
            <name>
              <surname>Praxedes</surname>
              <given-names>JN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Strelec MAAM, Pierin AMG, Mion J&#250;nior D. A influ&#234;ncia do conhecimento sobre a doen&#231;a e a atitude frente &#224; tomada de rem&#233;dios no controle da hipertens&#227;o arterial. Arq Bras Cardiol. 2003; 81 (4): 349-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A influ&#234;ncia do conhecimento sobre a doen&#231;a e a atitude frente &#224; tomada de rem&#233;dios no controle da hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>349</fpage>
          <lpage>54</lpage>
          <issue>4</issue>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Strelec</surname>
              <given-names>MAAM</given-names>
            </name>
            <name>
              <surname>Pierin</surname>
              <given-names>AMG</given-names>
            </name>
            <name>
              <surname>Mion J&#250;nior</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Sanchez CG, Pierin AM, Mion Junior D. Perfil do paciente hipertenso atendido em pronto socorro: compara&#231;&#227;o com hipertensos em tratamento ambulatorial. Rev Enf USP. 2004; 38 (1): 90-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Perfil do paciente hipertenso atendido em pronto socorro: compara&#231;&#227;o com hipertensos em tratamento ambulatorial</article-title>
          <source>Rev Enf USP</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>90</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Pierin</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Mion Junior</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Pierin AMG. Hipertens&#227;o arterial: uma proposta para o cuidar. Barueri: Manole; 2004.</mixed-citation>
        <element-citation publication-type="book">
          <source>Hipertens&#227;o arterial: uma proposta para o cuidar</source>
          <date>
            <year>2004</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Pierin</surname>
              <given-names>AMG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Fletcher A. Quality of life in the management of hypertension. Clin and Exper Hypertension. 1999; 21 (5-6): 961-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Quality of life in the management of hypertension</article-title>
          <source>Clin and Exper Hypertension</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>961</fpage>
          <lpage>72</lpage>
          <issue>5-6</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fletcher</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Mano GMP, Souza VF, Pierin AMG, Lima JCL, Ignes EC, Ortega KC, et al. Assessment of the DIXTAL DX-2710 automated oscillometric device for blood pressure measurement with the validation protocols of the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI). Arq Bras Cardiol. 2002; 79 (6): 606-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Assessment of the DIXTAL DX-2710 automated oscillometric device for blood pressure measurement with the validation protocols of the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI)</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>606</fpage>
          <lpage>10</lpage>
          <issue>6</issue>
          <volume>79</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mano</surname>
              <given-names>GMP</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>VF</given-names>
            </name>
            <name>
              <surname>Pierin</surname>
              <given-names>AMG</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>JCL</given-names>
            </name>
            <name>
              <surname>Ignes</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Andrews FM, Withey SB. Developing measures of perceived life quality: results from several national surveys. Soc Indic Res. 1974; 1 (1): 1-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Developing measures of perceived life quality: results from several national surveys</article-title>
          <source>Soc Indic Res</source>
          <date>
            <year>1974</year>
          </date>
          <fpage>1</fpage>
          <lpage>26</lpage>
          <issue>1</issue>
          <volume>1</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Andrews</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Withey</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Costa JSD, Barcellos FC, Sclowitz ML, Sclowitz IKT, Castanheira M, Olinto MTA, et al. Preval&#234;ncia de hipertens&#227;o arterial em adultos e fatores associados: um estudo de base populacional urbana em Pelotas, Rio Grande do Sul, Brasil. Arq Bras Cardiol. 2007; 88 (1): 59-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia de hipertens&#227;o arterial em adultos e fatores associados: um estudo de base populacional urbana em Pelotas, Rio Grande do Sul, Brasil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>59</fpage>
          <lpage>65</lpage>
          <issue>1</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>JSD</given-names>
            </name>
            <name>
              <surname>Barcellos</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Sclowitz</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Sclowitz</surname>
              <given-names>IKT</given-names>
            </name>
            <name>
              <surname>Castanheira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Olinto</surname>
              <given-names>MTA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Jardim PCV, Gondim MRP, Monego ET, Moreira HG, Vitorino PVO, Souza WKSB, et al. Hipertens&#227;o arterial e alguns fatores de risco em uma capital brasileira. Arq Bras Cardiol. 2007; 88 (4): 452-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hipertens&#227;o arterial e alguns fatores de risco em uma capital brasileira</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>452</fpage>
          <lpage>7</lpage>
          <issue>4</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jardim</surname>
              <given-names>PCV</given-names>
            </name>
            <name>
              <surname>Gondim</surname>
              <given-names>MRP</given-names>
            </name>
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Vitorino</surname>
              <given-names>PVO</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>WKSB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Barbosa JB, Silva AAM, Santos AM, Monteiro J&#250;nior FC, Barbosa MM, Barbosa MM, et al. Preval&#234;ncia da hipertens&#227;o arterial em adultos e fatores associados em S&#227;o Lu&#237;s  MA. Arq Bras Cardiol. 2008; 91 (4): 260-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia da hipertens&#227;o arterial em adultos e fatores associados em S&#227;o Lu&#237;s - MA</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>260</fpage>
          <lpage>6</lpage>
          <issue>4</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Barbosa</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>AAM</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Monteiro J&#250;nior</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Sousa AL. Educando a pessoa hipertensa. In: Pierin AMG. Hipertens&#227;o arterial: uma proposta para o cuidar. Barueri: Manole; 2005. p. 165-84.</mixed-citation>
        <element-citation publication-type="book">
          <source>Hipertens&#227;o arterial: uma proposta para o cuidar</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>165</fpage>
          <lpage>84</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Sousa</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Pierin</surname>
              <given-names>AMG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Pierin AMG, Mion Junior D, Fukushima JT, Pinto AR, Kaminaga MM. O perfil de um grupo de pessoas de acordo com conhecimento e gravidade da doen&#231;a. Rev Esc Enferm USP. 2001; 35 (1): 11-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>O perfil de um grupo de pessoas de acordo com conhecimento e gravidade da doen&#231;a</article-title>
          <source>Rev Esc Enferm USP</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>11</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pierin</surname>
              <given-names>AMG</given-names>
            </name>
            <name>
              <surname>Mion Junior</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Kaminaga</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Noblat ACB, Lopes MB, Lopes AA. Ra&#231;a e les&#227;o de &#243;rg&#227;os-alvo da hipertens&#227;o arterial em pacientes atendidos em um ambulat&#243;rio universit&#225;rio de refer&#234;ncia na cidade de Salvador. Arq Bras Cardiol. 2004; 82 (2): 111-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ra&#231;a e les&#227;o de &#243;rg&#227;os-alvo da hipertens&#227;o arterial em pacientes atendidos em um ambulat&#243;rio universit&#225;rio de refer&#234;ncia na cidade de Salvador</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>111</fpage>
          <lpage>5</lpage>
          <issue>2</issue>
          <volume>82</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Noblat</surname>
              <given-names>ACB</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Lessa I, Fonseca J. Ra&#231;a, ader&#234;ncia ao tratamento e/ou consultas e ao controle da press&#227;o arterial. Arq Bras Cardiol. 1997; 68 (6): 443-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ra&#231;a, ader&#234;ncia ao tratamento e/ou consultas e ao controle da press&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>443</fpage>
          <lpage>9</lpage>
          <issue>6</issue>
          <volume>68</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lessa</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Carneiro G, Faria AN, Ribeiro Filho FF, Guimar&#227;es A, Ler&#225;rio D, Ferreira SRG, et al. Influ&#234;ncia da distribui&#231;&#227;o da gordura corporal sobre a preval&#234;ncia de hipertens&#227;o arterial e outros fatores de risco cardiovascular em indiv&#237;duos obesos. Rev Assoc Med Bras. 2003; 49 (3): 306-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influ&#234;ncia da distribui&#231;&#227;o da gordura corporal sobre a preval&#234;ncia de hipertens&#227;o arterial e outros fatores de risco cardiovascular em indiv&#237;duos obesos</article-title>
          <source>Rev Assoc Med Bras</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>306</fpage>
          <lpage>11</lpage>
          <issue>3</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carneiro</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Faria</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Ribeiro Filho</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ler&#225;rio</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>SRG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Peixoto MRG, Ben&#237;cio MHA, Latorre MRDO, Jardim PCBV. Circunfer&#234;ncia da cintura e &#237;ndice de massa corporal como preditores da hipertens&#227;o arterial. Arq Bras Cardiol. 2006; 87 (4): 462-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Circunfer&#234;ncia da cintura e &#237;ndice de massa corporal como preditores da hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>462</fpage>
          <lpage>70</lpage>
          <issue>4</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Peixoto</surname>
              <given-names>MRG</given-names>
            </name>
            <name>
              <surname>Ben&#237;cio</surname>
              <given-names>MHA</given-names>
            </name>
            <name>
              <surname>Latorre</surname>
              <given-names>MRDO</given-names>
            </name>
            <name>
              <surname>Jardim</surname>
              <given-names>PCBV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Pimenta AM, Kac G, GazzinellA, Corr&#234;a-Oliveira R, Vel&#225;squez-Mel&#233;ndez G. Associa&#231;&#227;o entre obesidade central, triglicer&#237;deos e hipertens&#227;o arterial em uma &#225;rea rural do Brasil. Arq Bras Cardiol. 2008; 90 (6): 419-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Associa&#231;&#227;o entre obesidade central, triglicer&#237;deos e hipertens&#227;o arterial em uma &#225;rea rural do Brasil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>419</fpage>
          <lpage>25</lpage>
          <issue>6</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pimenta</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kac</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>GazzinellA</surname>
            </name>
            <name>
              <surname>Corr&#234;a-Oliveira</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vel&#225;squez-Mel&#233;ndez</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106 (3): 286-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>286</fpage>
          <lpage>8</lpage>
          <issue>3</issue>
          <volume>106</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reaven</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Silveira LMC, Ribeiro VMB. Grupo de ades&#227;o ao tratamento: espa&#231;o de "ensinagem" para profissionais de sa&#250;de e pacientes. Interface (Botucatu). 2005; 9 (16): 91-104.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Grupo de ades&#227;o ao tratamento: espa&#231;o de "ensinagem" para profissionais de sa&#250;de e pacientes</article-title>
          <source>Interface (Botucatu)</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>91</fpage>
          <lpage>104</lpage>
          <issue>16</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silveira</surname>
              <given-names>LMC</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>VMB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Bigal ME. Cefal&#233;ia dos dist&#250;rbios metab&#243;licos e end&#243;crinos. Migr&#226;neas Cefal&#233;ias. 2003; 6 (2): 59-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cefal&#233;ia dos dist&#250;rbios metab&#243;licos e end&#243;crinos</article-title>
          <source>Migr&#226;neas Cefal&#233;ias</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>59</fpage>
          <lpage>61</lpage>
          <issue>2</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bigal</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Scuteri A, Bos AJ, Brant LJ, Talbot L, Lakatta EG, Fleg JL. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med. 2001; 135 (4): 229-38.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women</article-title>
          <source>Ann Intern Med</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>229</fpage>
          <lpage>38</lpage>
          <issue>4</issue>
          <volume>135</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Scuteri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bos</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Talbot</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lakatta</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Fleg</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Weir MR, Maibach EW, Bakris GL, Black HR, Chawla P, Messerli FH, et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med. 2000; 160 (4): 481-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Implications of a health lifestyle and medication analysis for improving hypertension control</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>481</fpage>
          <lpage>90</lpage>
          <issue>4</issue>
          <volume>160</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weir</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Maibach</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Bakris</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Chawla</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Messerli</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Jesus ES, Augusto MAO, Gusm&#227;o J, Mion Jr D, Ortega K, Pierin AMG. Profile of hypertensive patients: biosocial characteristics, knowledge, and treatment compliance. Acta Paul Enferm. 2008; 21 (1): 59-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Profile of hypertensive patients: biosocial characteristics, knowledge, and treatment compliance</article-title>
          <source>Acta Paul Enferm</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>59</fpage>
          <lpage>65</lpage>
          <issue>1</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jesus</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Augusto</surname>
              <given-names>MAO</given-names>
            </name>
            <name>
              <surname>Gusm&#227;o</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mion Jr</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pierin</surname>
              <given-names>AMG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Daly J, Sindone AP, Thompson DR, Hancock K, Chang E, Davidson P. Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review. Prog Cardiovasc Nurs. 2002; 17 (4): 8-17.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review</article-title>
          <source>Prog Cardiovasc Nurs</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>8</fpage>
          <lpage>17</lpage>
          <issue>4</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Daly</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sindone</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Hancock</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Esler M, Schwarz R. Management of hypertension complicated by psychiatric comorbidity. J Clin Hypertens. 2007; 9 (9): 714-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Management of hypertension complicated by psychiatric comorbidity</article-title>
          <source>J Clin Hypertens</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>714</fpage>
          <lpage>5</lpage>
          <issue>9</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Esler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Art&#237;culos Originales</subject>
        </subj-group>
      </article-categories>
      <title-group/>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <bold>Variables biopsicosociales y actitudes frente al tratamiento influencian la hipertensi&#243;n complicada</bold>
      </p>
      <p>
        <bold>Angela Maria Geraldo Pierin<sup>I</sup>; Elaine dos Santos Jesus<sup>I</sup>; M&#244;nica Aparecida de Oliveira Augusto<sup>I</sup>; Josiane Gusm&#227;o<sup>II</sup>; K&#225;tia Ortega<sup>II</sup>; D&#233;cio Mion Jr<sup>II</sup></bold>
      </p>
      <p><sup>I</sup>Escola de Enfermagem - Universidade de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>II</sup>Unidade de Hipertens&#227;o - Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> La hipertensi&#243;n complicada puede ser influenciada por las caracter&#237;sticas de los pacientes hipertensos.</p>
      <p><bold>OBJETIVOS:</bold> Asociar la condici&#243;n de hipertensi&#243;n complicada con variables biosociales, tales como las actitudes y las creencias sobre la enfermedad y el tratamiento y el bienestar subjetivo.</p>
      <p><bold>M&#201;TODOS:</bold> Fueron estudiados 251 hipertensos no complicados (PAS <underline>&gt;</underline> 140 mmHg y/o 90 <underline>&lt;</underline> PAD &lt; 110 mmHg para pacientes sin tratamiento y PAD &lt; 110mmHg para pacientes con tratamiento, sin lesiones en &#243;rganos-blanco y otras enfermedades) y 260 hipertensos complicados (PAD <underline>&gt;</underline> 110 mmHg con o sin tratamiento, con lesiones en &#243;rganos-blanco u otras enfermedades).</p>
      <p><bold>RESULTADOS:</bold> Los hipertensos complicados fueron significativamente diferentes de los no complicados (p &lt; 0,05) en relaci&#243;n a: 1 - Predominio de hombres, no blancos (53,0%), mayor &#237;ndice de masa corporal (29,5 &#177; 4,6 <italic>vs</italic> 28,5 &#177; 4,0 kg/m<sup>2</sup>), m&#225;s de 10 a&#241;os de enfermedad (54,0%), realizaci&#243;n de tratamiento anterior (53,0%) y referencia de tristeza en relaci&#243;n a su vida como un todo (74,0%); 2 - Los hipertensos complicados nunca llevan los remedios cuando viajan (59,0%), ni los compran antes de acabar (71,0%) y raramente siguen las orientaciones sobre alimentaci&#243;n (69,0%); 3 - Los hipertensos no complicados relataron m&#225;s jaqueca, dolor articular y, entre las mujeres, presencia de menopausia y tratamiento de reposici&#243;n hormonal; 4 - De los que ten&#237;an la presi&#243;n controlada (&lt; 140/90 mmHg), 61,9% eran hipertensos no complicados; y 5 - Los hipertensos complicados desconoc&#237;an que el tratamiento puede evitar problemas renales y desconoc&#237;an aun que la hipertensi&#243;n tambi&#233;n puede afectar a personas j&#243;venes</p>
      <p><bold>CONCLUSI&#211;N:</bold> Hipertensos complicados presentaron m&#225;s caracter&#237;sticas estructurales y psicosociales desfavorables, m&#225;s actitudes negativas frente al tratamiento y desconocen la enfermedad. (Arq Bras Cardiol 2010;95(5):648-654)</p>
      <p><bold>Palabras-clave:</bold> Hipertensi&#243;n/complicaciones/terapia, rechazo del paciente al tratamiento, hipertensi&#243;n/aspectos psicosociales.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Estudios epidemiol&#243;gicos demuestran que niveles elevados de presi&#243;n arterial aumentan el riesgo de enfermedad vascular cerebral<sup>1</sup>, enfermedades arteriales coronarias<sup>2</sup>, insuficiencia card&#237;aca congestiva<sup>3</sup>, insuficiencia renal cr&#243;nica<sup>4</sup> y afectaci&#243;n vascular<sup>5</sup>. Adem&#225;s de eso, la hipertensi&#243;n arterial presenta prevalencia elevada y, en nuestro medio, su frecuencia var&#237;a entre 22,3% y 43,9%<sup>6</sup>. Mientras tanto, los &#237;ndices de control de la enfermedad son bajos, alrededor de 30,0%<sup>7,8</sup>, entre otros factores, principalmente debido a la baja adhesi&#243;n al tratamiento. En ese sentido, es importante identificar factores que puedan interferir en el proceso de adhesi&#243;n, sean relacionados al paciente, a la enfermedad, al tratamiento y a los aspectos institucionales, entre otros.</p>
      <p>Entre los aspectos relacionados al hipertenso que pueden influenciar la adhesi&#243;n al tratamiento, se destacan el g&#233;nero, edad, etnia, estado civil, escolaridad y nivel socioecon&#243;mico. Tambi&#233;n las creencias de salud y h&#225;bitos de vida merecen ser mencionadas. En relaci&#243;n a la enfermedad, son relevantes el conocimiento, la cronicidad, la ausencia de s&#237;ntomas y las consecuencias tard&#237;as. Costo, efectos indeseables de las drogas, esquemas complejos y empeoramiento de la calidad de vida son factores relativos al tratamiento medicamentoso antihipertensivo<sup>9</sup>, en ese sentido, los m&#233;todos usados para reducir la presi&#243;n arterial no deben interferir negativamente en la calidad de vida del paciente<sup>10</sup>.</p>
      <p>Otro punto que se destaca es que generalmente los hipertensos pueden presentar comorbilidades o lesiones en &#243;rganos-blanco ("hipertensos complicados"), que requieren otros tratamientos espec&#237;ficos y que pueden aumentar la dificultad del control de la hipertensi&#243;n arterial. Entre las comorbilidades m&#225;s frecuentes, est&#225;n la diabetes mellitus, las insuficiencias card&#237;aca y renal, la enfermedad coronaria y el accidente cerebro vascular, que aumentan el riesgo de mortalidad cardiovascular.</p>
      <p>En ese contexto, los profesionales del &#225;rea de la salud, que act&#250;an con hipertensos, tienen papel fundamental en el sentido de caracterizar la problem&#225;tica del hipertenso, teniendo en consideraci&#243;n todos los aspectos relacionados a sus caracter&#237;sticas, de modo que, basados en datos reales y concretos, tengan condiciones para planificar y prestar asistencia individualizada a fin de favorecer la adhesi&#243;n al tratamiento, con el control efectivo de la enfermedad.</p>
      <p>De esa forma, el presente estudio tuvo como objetivo asociar la condici&#243;n de hipertensi&#243;n complicada y no complicada con las siguientes variables: 1) biosociales; 2) actitudes y creencias sobre la enfermedad y tratamiento; 2) control de la presi&#243;n arterial; y 4) sentimiento en relaci&#243;n a la vida como un todo.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>El estudio fue realizado en el servicio ambulatorio de la Liga de Hipertensi&#243;n del Hospital de Cl&#237;nicas de la Facultad de Medicina de la Universidad de S&#227;o Paulo, despu&#233;s de aprobaci&#243;n por el Comit&#233; de &#201;tica. El estudio tuvo como criterios de inclusi&#243;n: hipertensos encima de 18 a&#241;os, de ambos sexos, sin restricci&#243;n de raza, con acuerdo del paciente para la participaci&#243;n en el estudio y firma del T&#233;rmino de Consentimiento Libre y Aclarado. Una muestra de conveniencia de 511 hipertensos fue compuesta, con rechazo m&#237;nimo para participaci&#243;n en el estudio.</p>
      <p>Los hipertensos fueron clasificados en complicados o no complicados. El grupo no complicado incluy&#243; 251 pacientes con presi&#243;n sist&#243;lica <underline>&gt;</underline> 140 mmHg y/o presi&#243;n diast&#243;lica &lt; 110 mmHg y <underline>&gt;</underline> 90 mmHg para pacientes sin tratamiento, y presi&#243;n diast&#243;lica &lt; 110 mmHg para pacientes con tratamiento medicamentoso, o sea, hipertensos nivel uno o dos<sup>6</sup>, que no presentaban lesiones en &#243;rganos-blanco cl&#237;nicamente evidentes o enfermedades asociadas (infarto agudo de miocardio, accidente cerebro vascular, diabetes mellitus, insuficiencia card&#237;aca, insuficiencia renal y/o nefropat&#237;as). El grupo complicado incluy&#243; 260 hipertensos con presi&#243;n diast&#243;lica <underline>&gt;</underline> 110 mmHg con o sin tratamiento, o sea hipertensos nivel tres<sup>6</sup>, o hipertensos con presi&#243;n diast&#243;lica <underline>&lt;</underline> 110 o &gt; 110 mmHg<bold>,</bold> que presentasen lesiones en &#243;rganos-blanco cl&#237;nicamente evidentes u otras enfermedades asociadas, seg&#250;n descriptas anteriormente.</p>
      <p>Los datos fueron colectados a trav&#233;s de entrevista con los pacientes, utilizando un formulario propio, con datos de identificaci&#243;n, aspectos econ&#243;mico y social, factores que puedan interferir en la adhesi&#243;n al tratamiento, creencias y conocimiento sobre la enfermedad y sobre el tratamiento. Los valores de la presi&#243;n arterial considerados fueron los resultados de la media de la 4&#170; y de la 5&#170; medidas, de una secuencia de 5 realizadas con aparato autom&#225;tico validado (DIXTAL DX2710)<sup>11</sup>, tipo oscilom&#233;trico, con el paciente sentado, brazo apoyado a la altura del coraz&#243;n, con uso de manguito de tama&#241;o adecuado, en ambiente calmo, sin estar con la vejiga llena, sin haber fumado, ingerido bebida cafe&#237;nada o comidas hace por lo menos 30 minutos, adem&#225;s de no haber realizado actividad f&#237;sica hace 60-90 minutos. Para evaluar el sentimiento del hipertenso en relaci&#243;n a su vida, fue usado un diagrama con 7 figuras de caras, Escala de Caras de Andrews, que es una escala visual de intervalos de 7 puntos, compuesta por caras estilizadas, refiri&#233;ndose al estado de humor que predomin&#243; frente a la pregunta "&#191;Cual de estas caras representa mejor su vida como un todo?"<sup>12</sup>.</p>
      <p>Las variables clasificatorias son presentadas descriptivamente en tablas conteniendo frecuencias absolutas (n) y relativas (%). La relaci&#243;n entre las variables fueron evaluadas con el test qui-cuadrado, test de la raz&#243;n de verosimilitud y el test exacto de Fisher.</p>
      <p>Las variables cuantitativas son presentadas en tablas conteniendo media y desv&#237;o-est&#225;ndar. En las variables cuantitativas, est&#225;n incluidas, edades, circunferencia abdominal, &#237;ndice de masa corporal y valores de la presi&#243;n arterial. Las medias, seg&#250;n los factores, fueron comparadas con tests param&#233;tricos (test t de Student o an&#225;lisis de variancia) o con tests no param&#233;tricos (test de la suma de puestos de Wilcoson el Kruskal-Wallis). El nivel de significancia adoptado fue 0,05. Los datos fueron procesados en el sistema <italic>SPSS</italic> 7.5.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>
        <bold>Caracter&#237;sticas de los hipertensos</bold>
      </p>
      <p>Fueron estudiados 511 hipertensos, con predominio del sexo femenino (67,9), de color blanco (56,4%), casados (66,9%), escolaridad de 1&#186; Grado (57,9%), personas que ejerc&#237;an actividades del hogar (43,2%) y renta familiar de hasta 5 salarios m&#237;nimos (56,0%). La media de edad se mantuvo en la 5&#170; d&#233;cada (53 &#177; 11 a&#241;os), el &#237;ndice de masa corporal permaneci&#243; en el l&#237;mite superior de la franja de sobrepeso (29,04 &#177; 4,35 Kg/m<sup>2</sup>). En relaci&#243;n a la medida de la cintura, 32,9% de los hombres ten&#237;an circunferencia abdominal mayor que 102 cm y 74,1% de las mujeres encima de 88 cm, que son los l&#237;mites m&#225;ximos tolerados. La media de presi&#243;n arterial fue de 151/92 mmHg. En cuanto a los h&#225;bitos de vida, 13,4% eran tabaquistas y un tercio ex-tabaquistas; 9,0% eran alcoh&#243;licos y 15,0% ex-alcoh&#243;licos. Apenas 22,6% refirieron practicar actividad f&#237;sica regularmente. En relaci&#243;n al diagn&#243;stico de la enfermedad, la mayor&#237;a (65,8%) sab&#237;a ser hipertenso hace m&#225;s de 5 a&#241;os, cerca de la mitad (51,5%) no ten&#237;a el h&#225;bito de medir la presi&#243;n, y los que la med&#237;an lo hac&#237;an en servicios de salud, en casa o en la farmacia.</p>
      <p>
        <bold>Variables que se asociaron a los hipertensos complicados y no complicados</bold>
      </p>
      <p>En las caracter&#237;sticas biosociales y antropom&#233;tricas, los hipertensos complicados eran (p &lt; 0,05) m&#225;s del sexo masculino, no blancos, responsables por la renta familiar, con niveles m&#225;s elevados de presi&#243;n arterial, del &#237;ndice de masa corporal y de la circunferencia abdominal (<xref ref-type="table" rid="tab1-body2">Tabla 1</xref>).</p>
      <table-wrap id="tab1-body2">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt01-es.jpg"/></table-wrap>
      <p>En relaci&#243;n a las actitudes frente al tratamiento de la hipertensi&#243;n, los hipertensos complicados informaron m&#225;s actitudes negativas (p &lt; 0,05), pues nunca o raramente llevan los remedios cuando viajan, no adquieren los medicamentos antes de que se acaben y tambi&#233;n nunca o raramente siguen las orientaciones sobre la alimentaci&#243;n (<xref ref-type="table" rid="tab2-body2">Tabla 2</xref>).</p>
      <table-wrap id="tab2-body2">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt02-es.jpg"/></table-wrap>
      <p>Se verific&#243; tambi&#233;n que los hipertensos complicados fueron significativamente distintos (p &lt; 0,05) de los no complicados por presentar m&#225;s referencia de dificultad de erecci&#243;n y adelgazamiento. En contrapartida, los hipertensos no complicados refirieron m&#225;s s&#237;ntomas como jaqueca y dolor en las articulaciones. Entre las mujeres, las hipertensas no complicadas estaban m&#225;s en la menopausia y hac&#237;an tratamiento de reposici&#243;n hormonal (p &lt; 0,05). Como era esperado, los niveles de presi&#243;n arterial fueron m&#225;s elevados en los hipertensos complicados y, entre el total de los hipertensos que presentaron la presi&#243;n controlada (&lt; 140/90 mmHg), la mayor&#237;a (61,9%) era de hipertensos no complicados (<xref ref-type="table" rid="tab3-body2">Tabla 3</xref>).</p>
      <table-wrap id="tab3-body2">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt03-es.jpg"/></table-wrap>
      <p>Se destaca aun que la condici&#243;n de ser hipertenso complicado se asoci&#243; con las siguientes variables (p &lt; 0,05): procur&#243; el servicio por cuenta propia, tiene m&#225;s tiempo de hipertensi&#243;n, ya hizo tratamiento anterior, hace uso de tratamiento medicamentoso antihipertensivo y ya us&#243; otros tratamientos, como remedios caseros y t&#233;s. Por otro lado, los no complicados midieron la presi&#243;n y estaba normal hace menos tiempo. En relaci&#243;n al conocimiento sobre la enfermedad, el grupo complicado present&#243; poco conocimiento, creyendo que el tratamiento no puede evitar problemas renales y que personas j&#243;venes no tienen presi&#243;n alta (<xref ref-type="table" rid="tab4-body2">Tabla 4</xref>).</p>
      <table-wrap id="tab4-body2">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt04-es.jpg"/></table-wrap>
      <p>De acuerdo con los datos de la <xref ref-type="table" rid="tab5-body2">Tabla 5</xref>, al ser preguntados como se sent&#237;an en relaci&#243;n a su vida como un todo, los hipertensos no complicados se&#241;alaron m&#225;s la cara 1, que se relaciona a un mayor grado de satisfacci&#243;n y los complicados, la cara 7, que caracteriza un menor grado de satisfacci&#243;n en relaci&#243;n a su vida como un todo (p &lt; 0,05).</p>
      <table-wrap id="tab5-body2">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt05-es.jpg"/></table-wrap>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio mostr&#243; que hubo distinci&#243;n entre los grupos de hipertensos complicados y no complicados cuanto a las caracter&#237;sticas socioestructurales, control de la hipertensi&#243;n, actitudes y conocimiento sobre la enfermedad y tratamiento, predominando en el grupo complicado, variables que pueden interferir en la obtenci&#243;n de &#233;xito en la realizaci&#243;n del tratamiento.</p>
      <p>Los principales resultados mostraron que los hipertensos complicados eran m&#225;s del sexo masculino, no blancos y responsables por la renta familiar. La variable g&#233;nero merece atenci&#243;n, pues puede estar respaldada en el hecho de que las mujeres, por su condici&#243;n espec&#237;fica, demuestran mayor concientizaci&#243;n con su salud, lo que puede resultar en mayor adhesi&#243;n al tratamiento. Estudios han revelado la relaci&#243;n entre hipertensi&#243;n y g&#233;nero<sup>13-15</sup>.</p>
      <p>Investigaci&#243;n sobre la prevalencia de la hipertensi&#243;n arterial referida, sobre la percepci&#243;n de su origen y formas de control en el &#225;rea metropolitana de S&#227;o Paulo, mostr&#243; que las mujeres fueron las que m&#225;s buscaron asistencia. Se piensa que las mujeres parecen tener una percepci&#243;n m&#225;s clara de su condici&#243;n de salud y tambi&#233;n desarrollan mayores relaciones con los servicios de salud en raz&#243;n de sus atributos y funciones reproductivas<sup>16</sup>. Otro estudio, realizado en un ambulatorio de un hospital escuela de la ciudad de S&#227;o Paulo, evidenci&#243; que la falta de conocimiento sobre la enfermedad y el tratamiento tambi&#233;n se asoci&#243; con el sexo masculino y niveles de presi&#243;n arterial m&#225;s elevados<sup>17</sup>.</p>
      <p>De la misma forma que el g&#233;nero, la etnia tambi&#233;n se ha asociado con la hipertensi&#243;n. En el presente estudio, la mayor&#237;a de los hipertensos complicados era formada por no blancos (negra, mulata, mestiza), lo que confirma la prevalencia de mayores complicaciones en esas etnias, como fue revelado en el estudio en que la prevalencia de accidente cerebro vascular fue significantemente mayor en hipertensos negros o mulatos que en blancos, atendidos en un servicio de referencia para hipertensi&#243;n arterial de la ciudad de Salvador, BA<sup>18</sup>. Tambi&#233;n en esa misma ciudad, se relacion&#243; raza y adhesi&#243;n al tratamiento en un ambulatorio de hipertensi&#243;n. Los datos mostraron que los pacientes de color blanco adhirieron m&#225;s a las consultas y al tratamiento que los pacientes de raza negra. Los negros comparecieron menos al tratamiento y presentaron niveles pres&#243;ricos m&#225;s elevados<sup>19</sup>.</p>
      <p>Se debe destacar que la asociaci&#243;n entre etnia e hipertensi&#243;n est&#225; &#237;ntimamente relacionada a las condiciones socioecon&#243;micas poco favorables a las que esas personas est&#225;n sujetas, lo que puede ser ejemplificado por el hecho de que, en el grupo de los hipertensos complicados, los responsables por la renta familiar eran los propios pacientes. Tal situaci&#243;n puede demandar m&#225;s preocupaciones, lo que tal vez pueda ser decurrente de la mayor responsabilidad en su vida diaria, a veces dejando de lado los cuidados de la propia salud.</p>
      <p>Varios factores de estilo de vida parecen influenciar directamente los niveles de la presi&#243;n arterial, siendo la obesidad uno de los m&#225;s importantes, lo que puede ser refrendado por el hallazgo de que la media del &#237;ndice de masa corporal de los hipertensos estudiados estuvo en el l&#237;mite superior de la franja de sobrepeso. Cuando son analizados los dos grupos estudiados, los hipertensos complicados presentaron niveles m&#225;s elevados de presi&#243;n arterial, del &#237;ndice de masa corporal y de la media de la circunferencia abdominal.</p>
      <p>La pandemia de la obesidad actual es de gran importancia, pues afecta profundamente la calidad de vida de las personas, volvi&#233;ndose un gran problema en la sociedad, por ser un importante factor de riesgo cardiovascular. La literatura sobre ese asunto es amplia y contundente.</p>
      <p>Investigaci&#243;n de Carneiro et al<sup>20</sup> mostr&#243; mayor prevalencia de hipertensi&#243;n entre los individuos con obesidad grado III (67,1% hipertensos con IMC <underline>&gt;</underline> 40 kg/m<sup>2</sup>) en relaci&#243;n a aquellos con sobrepeso (23,0% hipertensos con IMC <underline>&gt;</underline> 25 y <underline>&lt;</underline> 29,9 kg/m<sup>2</sup>). Despu&#233;s de estratificaci&#243;n por edad, el mayor aumento del riesgo de hipertensi&#243;n ocurri&#243; entre los j&#243;venes, grupo en el cual este riesgo alcanz&#243; valor 7,5 veces mayor que en los individuos con &#237;ndice de masa corporal entre 25 y 29,9 kg/m<sup>2</sup><sup>20</sup>.</p>
      <p>En relaci&#243;n a la obesidad abdominal, datos que fueron evaluados en un estudio, que analiz&#243; la circunferencia de la cintura y el &#237;ndice de masa corporal como pronosticadores de la hipertensi&#243;n arterial, indicaron aumento significativo de la prevalencia de la hipertensi&#243;n con el aumento de la circunferencia de la cintura, para el total de hombres. Para las mujeres, independientemente de la franja et&#225;rea, la prevalencia de la hipertensi&#243;n aument&#243; tanto con el aumento del &#237;ndice de masa corporal, como con el aumento de la circunferencia de la cintura<sup>21</sup>.</p>
      <p>En otro estudio, se observ&#243; que edad, triglic&#233;ridos, circunferencia de la cintura y sexo fueron factores de riesgo independientes asociados a la hipertensi&#243;n<sup>22</sup>. Adem&#225;s de que la obesidad abdominal es uno de los componentes del s&#237;ndrome metab&#243;lico y ha sido relacionada con mayor riesgo cardiovascular<sup>23</sup>.</p>
      <p>Se agregan al escenario de factores intervinientes en la consecuci&#243;n adecuada del tratamiento antihipertensivo, las actitudes frente al mismo. Los hipertensos complicados, cuando comparados a los no complicados, presentan m&#225;s comportamientos que pueden influenciar negativamente, como nunca o raramente llevar los remedios cuando viajan, no seguir las orientaciones sobre alimentaci&#243;n y no adquirir los remedios antes de que se acaben. De esa forma, la adhesi&#243;n al tratamiento se ve perjudicada, con consecuente control menos satisfactorio de la hipertensi&#243;n arterial. Los comportamientos y las actitudes est&#225;n arraigados en la conducta de las personas y requieren del equipo de salud conocimiento y habilidad de pr&#225;cticas de educaci&#243;n a fin de obtener cambios o minimizar actitudes que puedan comprometer la realizaci&#243;n adecuada del tratamiento.</p>
      <p>La educaci&#243;n de las personas con enfermedades cr&#243;nicas, como la hipertensi&#243;n, tiene como finalidad influenciar el comportamiento del paciente en la obtenci&#243;n de cambios y manutenci&#243;n de las mismas. Los objetivos se relacionan a: ayudar el paciente a entender, conocer y aceptar la enfermedad; conocer y reconocer comportamientos de riesgo; informar sobre decisiones del tratamiento y diagn&#243;stico; negociar y cumplir propuestas de tratamiento; y enfrentar problemas de manutenci&#243;n del tratamiento<sup>16</sup>. As&#237;, el tratamiento del paciente portador de enfermedad cr&#243;nica debe favorecer la adaptaci&#243;n a tal condici&#243;n, d&#225;ndole instrumentos para que, por medio de sus propios recursos, desarrolle mecanismos que permitan conocer su proceso salud/enfermedad de modo de identificar, evitar y prevenir complicaciones, da&#241;os y, sobre todo, mortalidad precoz<sup>24</sup>.</p>
      <p>La presencia de comorbilidades asociadas a la hipertensi&#243;n complicada, como por ejemplo la diabetes, ya era un hecho esperado, teniendo en vista que hac&#237;a parte de los criterios de inclusi&#243;n para este grupo. Sin embargo, la hipertensi&#243;n arterial y la diabetes mellitus representan importantes problemas de salud p&#250;blica en nuestro medio, en funci&#243;n de las altas tasas de prevalencias, sus complicaciones, adem&#225;s de configurarse como importantes factores de riesgo asociados a las enfermedades cardiovasculares, que por su vez ocupan el primer lugar en el perfil de morbimortalidad.</p>
      <p>La sobrevida de los pacientes, las barreras para el acceso a los servicios de salud, aspectos del comportamiento que determinan la b&#250;squeda espont&#225;nea de cuidados preventivos o curativos son factores que pueden influenciar en la prevalencia de complicaciones de &#243;rganos-blanco de la hipertensi&#243;n arterial en pacientes evaluados ambulatoriamente<sup>18</sup>.</p>
      <p>Se destacan aun los costos sociales y econ&#243;micos, decurrentes de la asistencia a la salud, la jubilaci&#243;n precoz, el ausentismo al trabajo y otras incapacidades.</p>
      <p>En relaci&#243;n a la presencia de otros problemas de salud, los hipertensos no complicados presentaron m&#225;s s&#237;ntomas, como por ejemplo jaqueca, lo que puede ser explicado por la mayor concentraci&#243;n de mujeres en este grupo y tal alteraci&#243;n est&#225; m&#225;s presente en el sexo femenino<sup>25</sup>. Aun en relaci&#243;n a las mujeres no complicadas, se verific&#243; que realizaban m&#225;s tratamiento de reposici&#243;n hormonal, cuando fueron comparadas con las hipertensas complicadas. La relaci&#243;n entre el tratamiento de reposici&#243;n hormonal despu&#233;s de la menopausia y la protecci&#243;n para las enfermedades cardiovasculares aun es bastante discutida, sin embargo, estudio de Scuteri y colegas verific&#243; que, en hipertensas bajo esa terapia, hubo peque&#241;a reducci&#243;n de la presi&#243;n sist&#243;lica<sup>26</sup>. Adem&#225;s de eso, las mujeres tienden a procurar m&#225;s por la asistencia y parecen tener una percepci&#243;n m&#225;s clara de su condici&#243;n de salud, desarrollando mayores relaciones con los servicios de salud en raz&#243;n de sus atributos y funciones reproductivas.</p>
      <p>Se destaca aun que la referencia de "dificultad de erecci&#243;n" fue m&#225;s se&#241;alada por los hipertensos complicados, la que puede ser justificada principalmente por la asociaci&#243;n de la hipertensi&#243;n arterial y diabetes, por el uso de n&#250;mero mayor de medicamentos, por las otras comorbilidades como insuficiencia renal o hasta porque en este grupo la mayor&#237;a era del sexo masculino.</p>
      <p>Otros hallazgos que pueden influenciar la condici&#243;n de los hipertensos complicados fueron mayor tiempo de enfermedad y de tratamiento asociados a poco conocimiento, como no saber que el tratamiento puede evitar problemas renales y que personas j&#243;venes pueden tener hipertensi&#243;n arterial. El conocimiento sobre la enfermedad y sobre el tratamiento tambi&#233;n es una variable a ser considerada en el contexto de la adhesi&#243;n al tratamiento.</p>
      <p>De un modo general, datos de estudios<sup>7,27,28</sup> muestran que los hipertensos poseen la informaci&#243;n sobre su problem&#225;tica de salud, sin embargo no est&#225;n debidamente controlados. La discrepancia entre tener informaci&#243;n al respecto de la enfermedad y tratamiento y conseguir controlar la presi&#243;n arterial apunta a la diferencia esencial entre conocimiento y adhesi&#243;n.</p>
      <p>Se agrega aun que, en la tentativa de evaluar como se sent&#237;an en relaci&#243;n a su vida como un todo, que ser&#237;a una posibilidad de evaluaci&#243;n de calidad de vida, la presente investigaci&#243;n verific&#243; que los hipertensos complicados relataron m&#225;s insatisfacci&#243;n que los hipertensos no complicados. La relaci&#243;n entre caracter&#237;sticas de la personalidad y adhesi&#243;n al tratamiento es controvertida, sin embargo, variables, como sentimiento de bienestar, socializaci&#243;n y capacidad de ser igual a otros, son elementos de medida de la personalidad y pueden asociarse con la adhesi&#243;n al tratamiento, contribuyendo para el control de la enfermedad<sup>29,30</sup>.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Entre los hipertensos complicados, caracter&#237;sticas estructurales y psicosociales desfavorables, actitudes negativas frente al tratamiento y desconocimiento sobre la enfermedad pueden haber tenido influencia en el bajo porcentual de control de la presi&#243;n arterial verificado.</p>
      <p>No se descarta la posibilidad de limitaciones del estudio, com&#250;n en estudios observacionales, tales como posibilidades de sesgo de selecci&#243;n, envolvimiento de factores de confusi&#243;n y hallazgos ocasionales en el an&#225;lisis. Sin embargo, se considera que los profesionales del &#225;rea de la salud que act&#250;an junto a los hipertensos deben proveer estrategias diferenciadas y planificar sus acciones para prestar una asistencia amplia y de calidad que atienda a las reales necesidades de estos pacientes.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiamiento</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiamiento externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>No hay vinculaci&#243;n de este estudio a programas de postgrado.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Biopsychosocial variables and attitudes towards treatment influence complicated hypertension</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Complicated hypertension can be influenced by the characteristics of hypertensive patients. OBJECTIVE: To associate the condition of complicated hypertension with biosocial variables such as attitudes and beliefs about the disease and treatment and subjective well-being. METHODS: We studied 251 uncomplicated hypertensive patients (SBP &gt; 140 mmHg and/or 90 &lt; DBP &lt; 110 mmHg for patients under no treatment and DBP &lt;110mmHg for patients under treatment without target organ damage and other diseases) and 260 complicated hypertensive patients (DBP &gt; 110 mmHg with or without treatment, with target organ damage or other diseases). RESULTS: Complicated hypertensive patients were significantly different from uncomplicated ones (p &lt;0.05) in relation to: 1 - Prevalence of men, not white (53.0%), higher body mass index (29.5 &#177; 4.6 vs 28.5 &#177; 4.0 kg/m&#178;), over 10 years of disease (54.0%), completion of previous treatment (53.0%) and reports of sadness about life as a whole (74.0%) 2 - Complicated hypertensive patients never bring the drugs when they travel (59.0%), nor do they buy them before running out the drugs (71.0%) and rarely follow eating guidelines (69.0%) 3 - Uncomplicated hypertensive patients showed no more migraines, joint pain and, among women, menopausal status and hormone replacement therapy, and 4 - Of those who had pressure control (&lt; 140/90 mmHg), 61.9% were uncomplicated hypertensive patients; and 5 - Complicated hypertensive patients were not aware that treatment can prevent kidney problems and they thought that young people do not have high blood pressure. CONCLUSION: Complicated hypertensive patients showed more negative structural and psychosocial characteristics, more negative attitudes towards treatment and are unaware of the disease.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Hypertension</kwd>
        <kwd>Hypertension</kwd>
        <kwd>treatment refusal</kwd>
        <kwd>hypertension</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p><undefined id="tx-body3"/>Biopsychosocial variables and attitudes towards treatment influence complicated hypertension</p>
      <p>
        <bold>Angela Maria Geraldo Pierin<sup>I</sup>; Elaine dos Santos Jesus<sup>I</sup>; M&#244;nica Aparecida de Oliveira Augusto<sup>I</sup>; Josiane Gusm&#227;o<sup>II</sup>; K&#225;tia Ortega<sup>II</sup>; D&#233;cio Mion Jr<sup>II</sup></bold>
      </p>
      <p><sup>I</sup>Escola de Enfermagem - Universidade de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>II</sup>Unidade de Hipertens&#227;o - Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Complicated hypertension can be influenced by the characteristics of hypertensive patients.</p>
      <p><bold>OBJECTIVE:</bold> To associate the condition of complicated hypertension with biosocial variables such as attitudes and beliefs about the disease and treatment and subjective well-being.</p>
      <p><bold>METHODS:</bold> We studied 251 uncomplicated hypertensive patients (SBP <underline>&gt;</underline> 140 mmHg and/or 90 <underline>&lt;</underline> DBP &lt; 110 mmHg for patients under no treatment and DBP &lt;110mmHg for patients under treatment without target organ damage and other diseases) and 260 complicated hypertensive patients (DBP <underline>&gt;</underline> 110 mmHg with or without treatment, with target organ damage or other diseases).</p>
      <p><bold>RESULTS:</bold> Complicated hypertensive patients were significantly different from uncomplicated ones (p &lt;0.05) in relation to: 1 - Prevalence of men, not white (53.0%), higher body mass index (29.5 &#177; 4.6 vs 28.5 &#177; 4.0 kg/m<sup>2</sup>), over 10 years of disease (54.0%), completion of previous treatment (53.0%) and reports of sadness about life as a whole (74.0%) 2 - Complicated hypertensive patients never bring the drugs when they travel (59.0%), nor do they buy them before running out the drugs (71.0%) and rarely follow eating guidelines (69.0%) 3 - Uncomplicated hypertensive patients showed no more migraines, joint pain and, among women, menopausal status and hormone replacement therapy, and 4 - Of those who had pressure control (&lt; 140/90 mmHg), 61.9% were uncomplicated hypertensive patients; and 5 - Complicated hypertensive patients were not aware that treatment can prevent kidney problems and they thought that young people do not have high blood pressure.</p>
      <p><bold>CONCLUSION:</bold> Complicated hypertensive patients showed more negative structural and psychosocial characteristics, more negative attitudes towards treatment and are unaware of the disease. </p>
      <p><bold>Key words:</bold> Hypertension/complications/therapy; treatment refusal; hypertension/psychology.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Epidemiological studies show that high levels of blood pressure increase the risk of cerebrovascular disease<sup>1</sup>, coronary artery diseases<sup>2</sup>, congestive heart failure<sup>3</sup>, chronic renal failure<sup>4</sup> and vasculitis<sup>5</sup>. Furthermore, hypertension has a high prevalence and in our country, its frequency varies from 22.3% to 43.9%<sup>6</sup>. However, rates of disease control are low, around 30.0%<sup>7,8</sup>, among other factors, mainly due to poor adherence to treatment. Thus, it is important to identify factors that may affect the adherence process, related to the patient, to the disease, to the treatment and institutional aspects, among others. </p>
      <p>Among the aspects related to hypertension that may influence adherence to treatment, we emphasize the gender, age, ethnicity, marital status, educational level and socioeconomic status. Health beliefs and lifestyle are noteworthy. In relation to the disease, knowledge, chronicity, absence of symptoms and late consequences are relevant. Cost, side effects of drugs, complex schemes and poor quality of life relate to antihypertensive drug treatment<sup>9</sup>. In this sense, the methods used to reduce blood pressure should not adversely affect the quality of life of the patient<sup>10</sup>.</p>
      <p>Another point that stands out is that hypertensive patients usually may have comorbidities or target organ damage ("complicated hypertensive patients") that require other specific treatments that may increase the difficulty of controlling high blood pressure. Among the most common comorbidities, are diabetes mellitus, heart and kidney failure, coronary heart disease and cerebrovascular accident, which increase the risk of cardiovascular mortality.</p>
      <p>In this context, health professionals, who work together with hypertensive patients, play a fundamental role in order to characterize the problem of hypertension, taking into consideration all aspects relating to their characteristics, so that, based on real and concrete data, they are able to plan and provide individualized assistance to promote adherence to treatment, with effective control of the disease.</p>
      <p>Thus, this study aims at associating the condition of complicated and uncomplicated hypertension with the following variables: 1) biosocial, 2) attitudes and beliefs on the disease and treatment, 2) blood pressure control; and 4) feeling about life as a whole. </p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The study was conducted in the outpatient clinic of the League of Hypertension of the Hospital of the Faculty of Medicine, University of S&#227;o Paulo (Brazil), after approval by the Ethics Committee. The study adopted the following inclusion criteria: hypertensive patients older than 18, from both sexes, without race restriction, with patient's consent to participate in the study and signing the consent form. A convenience sample consisted of 511 hypertensive patients, with minimal refusal to participate in the study.</p>
      <p>Hypertensive patients were classified as complicated or uncomplicated. The uncomplicated group included 251 patients with systolic pressure <underline>&gt;</underline> 140 mmHg and/or diastolic pressure &lt; 110 mmHg and <underline>&gt;</underline> 90 mmHg for untreated patients, and diastolic pressure &lt; 110 mmHg for patients with drug treatment, or hypertensive patients under stage one or 2<sup>6</sup>, which showed no target organ damage clinically evident or associated diseases (myocardial infarction, acidente vascular cerebral, diabetes mellitus, heart failure, kidney failure and/or nephropathy). The complicated group included 260 hypertensive patients with diastolic pressure <underline>&gt;</underline> 110 mmHg with or without treatment, or hypertensive patients under stage three<sup>6</sup>, or hypertension with diastolic pressure <underline>&lt;</underline> 110 or &gt; 110 mmHg, which showed clinically evident target organ damage or other diseases, as previously described. </p>
      <p>Data were collected through interviews with patients, using a form provided with identification data, economic and social aspect, factors that may interfere with treatment adherence, beliefs and knowledge about the disease and treatment. Blood pressure values considered were the average result of the 4<sup>th</sup> and 5<sup>th</sup> measurements of a sequence of five performed with validated automatic device (DIXTAL DX2710)<sup>11</sup>, oscillometric type, with the patient seated, arm resting at heart level, using a cuff of appropriate size, in a quiet environment, with no full bladder, without having smoked, had caffeinated beverage or meal at least 30 minutes before, and without having practiced any physical activity for 60 to 90 minutes. To assess hypertensive patients' feeling in relation to their life, we used a diagram with seven pictures of faces, Andrews' Faces Scale, which is a visual scale with intervals of 7 points, consisting of stylized faces, referring to the mood that prevailed before the question "Which of these faces best represents your life as a whole?"<sup>12</sup>.</p>
      <p>Categorical variables are presented descriptively in tables with absolute (n) and relative (%) frequencies. The relationship between variables was assessed with chi-square test, likelihood ratio test or Fisher's exact test. </p>
      <p>Quantitative variables are presented in tables with mean and standard deviation. Quantitative variables included age, waist circumference, body mass index and blood pressure values. The means, according to the factors, were compared with parametric tests (Student t test or analysis of variance) or nonparametric tests (Wilcoxon or Kruskal-Wallis' rank sum test). The level of significance was 0.05. The data were processed using the SPSS 7.5 system.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>Characteristics of hypertensive patients</bold>
      </p>
      <p>We studied 511 hypertensive patients, predominantly female (67.9), white (56.4%), married (66.9%), educational level of Primary Education (57.9%), homemakers (43.2%) and family income of up to five minimum salaries (56.0%). Average age remained in the 5<sup>th</sup> decade (53 &#177; 11 years), body mass index remained at the upper limit of the overweight range (29.04 &#177; 4.35 kg/m<sup>2</sup>). In relation to the waist, 32.9% of men had waist circumference greater than 102 cm and 74.1% of women above 88 cm, which is the maximum permissible levels. Mean blood pressure was 151/92 mmHg. As for lifestyle, 13.4% were smokers and one third were former smokers; 9.0% were alcoholics and 15.0% former alcoholics. Only 22.6% reported practicing regular physical activity. Regarding the diagnosis of disease, the majority (65.8%) was aware of being hypertensive for more than five years and about half of them (51.5%) had the habit of measuring blood pressure, and those who did so, were used to do that in health centers, at home or at the pharmacy.</p>
      <p>
        <bold>Variables associated with complicated and uncomplicated hypertensive patients</bold>
      </p>
      <p>In biosocial and anthropometric characteristics, complicated hypertensive patients (p &lt; 0.05) were mostly male, non-white, responsible for the family income, with higher blood pressure levels, body mass index and waist circumference (<xref ref-type="table" rid="tab01-body3">Table 1</xref>).</p>
      <table-wrap id="tab01-body3">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt01-en.jpg"/></table-wrap>
      <p>Regarding attitudes towards treatment of hypertension, complicated hypertensive patients reported more negative attitudes (p &lt; 0.05), for never or rarely bringing drugs when traveling, not getting the drugs before running out of them, and never or rarely following eating guidelines (<xref ref-type="table" rid="tab02-body3">Table 2</xref>).</p>
      <table-wrap id="tab02-body3">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt02-en.jpg"/></table-wrap>
      <p>It was also found that complicated hypertensive patients were significantly different (p &lt; 0.05) from the uncomplicated ones for reporting more difficulties with erection and weight loss. In contrast, uncomplicated hypertensive patients reported more symptoms such as headache and joint pain. Among women, uncomplicated hypertensive patients were more in menopause and were under hormone replacement therapy (p &lt; 0.05). As expected, blood pressure levels were higher in complicated hypertensive patients and, among the total number of hypertensive patients who had pressure control (&lt; 140/90 mmHg), the majority (61.9%) was uncomplicated hypertensive patients (<xref ref-type="table" rid="tab03-body3">Table 3</xref>). </p>
      <table-wrap id="tab03-body3">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt03-en.jpg"/></table-wrap>
      <p>Note also that the condition of being a complicated hypertensive patient was associated with the following variables (p &lt; 0.05): sought help on their own, have had hypertension for a longer time, had previous treatment, are under antihypertensive drug treatment and have used other treatments such as homemade medicines and tea. On the other hand, uncomplicated hypertensive patients measured blood pressure and it had been normal for a shorter time. In relation to awareness about the disease, the complicated group had little knowledge, believing that the treatment cannot prevent kidney problems and that young people do not have high blood pressure (<xref ref-type="table" rid="tab04-body3">Table 4</xref>).</p>
      <table-wrap id="tab04-body3">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt04-en.jpg"/></table-wrap>
      <p>According to the data contained in <xref ref-type="table" rid="tab05-body3">Table 5</xref>, when asked how they felt about their life as a whole, most uncomplicated hypertensive patients pointed out face 1, which relates to a greater degree of satisfaction, and most complicated hypertensive patients pointed out face 7, which characterizes a lower degree of satisfaction with their life as a whole (p &lt; 0.05). </p>
      <table-wrap id="tab05-body3">
        <graphic xlink:href="1678-4170-abc-95-05-0648-00132-gt05-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This study reported a distinction among groups of complicated and uncomplicated hypertensive patients as to socio-structural characteristics, hypertension control, attitudes and knowledge about the disease and treatment, predominantly in the complicated group. These variables may interfere with a successful treatment.</p>
      <p>The main results showed that complicated hypertensive patients were mainly male, nonwhite, and responsible for family income. The gender variable deserves attention because it may be supported by the fact that women, due to their specific condition, demonstrate greater awareness about their health, which may result in greater adherence to treatment. Studies have revealed the relationship between hypertension and gender<sup>13-15</sup>. </p>
      <p>Research on the prevalence of reported hypertension, on the perception of its origin and forms of control in a metropolitan area of S&#227;o Paulo, showed that women were the ones who most sought out assistance. Women seem to have a more accurate perception of their health condition and also develop greater links with health services because of their attributes and reproductive functions<sup>16</sup>. Another study, performed in an outpatient clinic of a teaching hospital in S&#227;o Paulo, showed that lack of knowledge about the disease and treatment was also associated with male sex and higher blood pressure levels<sup>17</sup>. </p>
      <p>Just as gender, ethnicity has also been associated with hypertension. In this study, most complicated hypertensive patients were non-white (black, mulatto, mestizo), which confirms the prevalence of major complications in these ethnic groups, as revealed in the study in which the prevalence of cerebrovascular accident was significantly higher in hypertensive blacks or mulattos than in whites assisted at a referral center for hypertension in the city of Salvador, BA<sup>18</sup>. Also in that same city, race and treatment adherence was related at a hypertension outpatient care center. The data showed that white patients adhered more to the medical appointments and treatment than black patients. Blacks attended less to treatment and had higher blood pressure<sup>19</sup>. </p>
      <p>It should be emphasized that the association between ethnicity and hypertension is closely related to the unfavorable socioeconomic conditions to which such persons are subject, which can be exemplified by the fact that in the complicated hypertensive group, those responsible for the family income were the patients. Such a situation may demand more concerns, which may perhaps be due to greater responsibility in their daily lives, sometimes leaving aside cares with their own health. </p>
      <p>Several lifestyle factors seem to directly influence the levels of blood pressure, obesity being one of the most important ones, which can be endorsed by the finding that average body mass index of hypertensive patients studied was in the upper range limit of overweight. By analyzing both groups, complicated hypertensive patients showed higher levels of blood pressure, body mass index and average waist circumference. </p>
      <p>The current pandemic of obesity is of great importance because it profoundly affects the quality of life, becoming a major problem in society, being an important cardiovascular risk factor. The literature on this subject is broad and firm. </p>
      <p>Research conducted by Carneiro et al<sup>20</sup> showed a higher prevalence of hypertension among individuals with morbid obesity (67.1% hypertensive patients with BMI <underline>&gt;</underline> 40 kg/m<sup>2</sup>) than in those with overweight (23.0% hypertensive patients with BMI <underline>&gt;</underline> 25 and <underline>&lt;</underline> 29.9 kg/m<sup>2</sup>). After stratification by age, the highest increased risk of hypertension occurred among young people, where this risk was 7.5 times higher than in individuals with body mass index between 25 and 29.9 kg/m<sup>2 20</sup>.</p>
      <p>In relation to abdominal obesity, data evaluated in a study that analyzed waist circumference and body mass index as predictors of hypertension, indicated a significant increase in the prevalence of hypertension with increased waist circumference, for total men. For women, regardless of age, the prevalence of hypertension increased both with increased body mass index, and with increased waist circumference<sup>21</sup>.</p>
      <p>Another study reported that age, triglycerides, waist circumference and sex were independent risk factors associated with hypertension<sup>22</sup>. Besides that, abdominal obesity is a component of metabolic syndrome and has been associated with increased cardiovascular risk<sup>23</sup>.</p>
      <p>This scenario is further enhanced with intervening factors in proper follow-up of antihypertensive treatment, the attitudes to it. Complicated hypertensive patients compared to uncomplicated patients have more behaviors that may negatively influence, such as never or rarely bringing drugs when traveling, not following instructions on diet and not buying the drugs before running out of them. Thus, adherence to treatment is impaired, with consequent less satisfactory control of hypertension. The behaviors and attitudes are rooted in the conduct of individuals and require health team knowledge and skill of educational practices in order to change or minimize actions that may jeopardize proper treatment. </p>
      <p>The education of people with chronic diseases such as hypertension is intended to influence the behavior of the patient in obtaining and maintaining those changes. The goals relate to: helping patients understand, acknowledge and accept the disease; know and recognize risk behaviors; inform on decisions about treatment and diagnosis; negotiate and fulfill treatment proposals; and address treatment maintenance problems<sup>16</sup>. Thus, treatment of patients with chronic disease should facilitate compliance with this condition, equipping the patients for, through their own resources, developing mechanisms to get familiar with their health-disease process in order to identify, avoid and prevent complications, worsening, and above all, early mortality<sup>24</sup>.</p>
      <p>The presence of comorbidities associated with complicated hypertension, such as diabetes, was an expected fact, considering that it was part of the inclusion criteria for this group. However, hypertension and diabetes mellitus represent major public health problems in our country, due to the high prevalence rates, their complications, and for being important risk factors associated with cardiovascular diseases, which in turn rank first in the profile of morbidity and mortality. </p>
      <p>Patients' survival, barriers to access to health services, aspects of behavior that determine the spontaneous demand for preventive or curative care, are factors that may influence the prevalence of target organ complications of hypertension in patients evaluated in outpatient care centers<sup>18</sup>. </p>
      <p>The social and economic costs arising from health care, early retirement, absenteeism from work and other disabilities should also be emphasized. </p>
      <p>As for the presence of other health problems, uncomplicated hypertensive patients showed more symptoms such as migraine, which can be explained by the higher concentration of women in this group and this abnormality is more commonly found among females<sup>25</sup>. Also in relation to uncomplicated women, it was reported that a higher number of these were under hormone replacement therapy, compared with complicated hypertensive women. The relationship between hormone replacement therapy after menopause and protection for cardiovascular disease is still widely debated. However, a study conducted by Scuteri et al found that, in hypertensive patients under this therapy, there was a small reduction in systolic blood pressure<sup>26</sup>. Furthermore, women tend to seek more for health care and seem to have a more accurate perception of their health condition, developing greater links with health services because of their attributes and reproductive functions. </p>
      <p>Note also that "the difficulty of erection" was most often reported by complicated hypertensive patients, which can be justified mainly by the association of hypertension and diabetes, use of a higher number of drugs for other comorbidities such as renal failure or even because, in this group, most patients were male. </p>
      <p>Other findings that may influence the condition of complicated hypertensive patients were longer time of disease and treatment associated with poor knowledge, such as not knowing that treatment may prevent kidney problems and that young people may have hypertension. Knowledge about the disease and treatment is also a variable to be considered in the context of adherence to treatment. </p>
      <p>In general, data from studies<sup>7,27,28</sup> show that hypertensive patients have information about their health problems, but are not properly controlled. The discrepancy between having information about the disease and treatment and managing to control blood pressure points out to the essential difference between knowledge and adherence. </p>
      <p>In addition to that, in an attempt to assess how they felt about their life as a whole, which would be a possibility of assessing quality of life, this research found that complicated hypertensive patients reports more dissatisfaction than complicated hypertensive patients. The relationship between personality traits and adherence to treatment is controversial. However, variables such as sense of well-being, networking and ability to be like others, are elements that measure personality and may be associated with adherence to treatment, contributing for disease control<sup>29,30</sup>. </p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>Among complicated hypertensive patients, unfavorable structural and psychosocial characteristics, negative attitudes towards treatment and lack of knowledge about the disease could have influenced the low percentage of blood pressure control. </p>
      <p>We do not rule out the possibility of limitations in this study, which is common in observational studies, such as the potential selection bias, involvement of confounding factors and incidental findings in the analysis. However, it is considered that health professionals who work with hypertensive patients should provide distinguished strategies and plan their actions to provide a comprehensive and quality assistance that meets the real needs of these patients.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This study is not associated with any post-graduation program.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
